1,043
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells

ORCID Icon, , , , ORCID Icon, , , , , , ORCID Icon & ORCID Icon show all
Pages 1221-1230 | Received 27 Mar 2021, Accepted 05 Apr 2021, Published online: 19 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mehak, Rajkumar P Thummer & Lalit M. Pandey. (2023) Surface modified iron-oxide based engineered nanomaterials for hyperthermia therapy of cancer cells. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-47.
Read now

Articles from other publishers (2)

Ximing Yang, Miaozhi Gao, Runshi Xu, Yangyang Tao, Wang Luo, Binya Wang, Wenliang Zhong, Lan He & Yingchun He. (2022) Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors. Frontiers in Immunology 13.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.